(Q81152786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Liposome-DNA complexes infused intravenously inhibit tumor angiogenesis and elicit antitumor activity in dogs with soft tissue sarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1 reference

Kamstock D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Guth A

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Elmslie R

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Kurzman I

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Liggitt D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Coro L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Fairman J

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Dow S

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

306-317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700895

6 January 2020

exact match

0 references

cites work

Tumorigenesis and the angiogenic switch

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Endogenous angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Tumor angiogenesis: past, present and the near future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

The anti-angiogenic basis of metronomic chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Development of new drugs in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

VEGF blocking therapy in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Angiogenesis inhibitors in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Lack of antitumor activity of recombinant endostatin in a human neuroblastoma xenograft model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Antiangiogenic gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Intravenous delivery of an endostatin gene complexed in cationic lipid inhibits systemic angiogenesis and tumor growth in murine models

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Endostatin cDNA/cationic liposome complexes as a promising therapy to prevent lung metastases in osteosarcoma: study in a human-like rat orthotopic tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Undermining tumor angiogenesis by gene therapy: an emerging field

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Gene therapy delivery of endostatin enhances the treatment efficacy of radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Adeno-associated virus-mediated delivery of a mutant endostatin suppresses ovarian carcinoma growth in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Endostatin gene transfection using a cationic lipid: advantages of transfection before tumor cell inoculation and repeated transfection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Protamine enhances uptake of cationic liposomes in angiogenic microvessels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Tumor treatment with complexes of cationic lipid and noncoding plasmid DNA results in the induction of cytotoxic T cells and systemic tumor elimination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

1 reference

7 January 2021

Medical management of soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Principles of treatment for soft-tissue sarcomas in the dog.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Quantitative RT-PCR to evaluate in vivo expression of multiple transgenes using a common intron

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Genes expressed in human tumor endothelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors in tumor-bearing dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

CpG oligodeoxynucleotide enhances tumor response to radiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700895

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700895

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16138118%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference